Soft contact lenses eyed as new solutions to monitor ocular diseases
New contact lens technology to help diagnose and monitor medical conditions may soon be ready for clinical trials.
Mar 10, 2021
0
49
New contact lens technology to help diagnose and monitor medical conditions may soon be ready for clinical trials.
Mar 10, 2021
0
49
A Purdue University neuroscientist's findings suggest that the brain is not as efficient as we think.
Mar 8, 2021
0
54
A novel form of a drug used to treat osteoporosis that comes with the potential for fewer side effects may provide a new option for patients.
Jan 6, 2021
0
139
For pregnant women, the elderly and those with weakened immune systems, listeriosis is a serious foodborne illness often linked to deli meats, fresh produce and dairy products. Even with antibiotic treatment, listeriosis ...
Dec 16, 2020
0
23
A new approach to cancer immunotherapy has the potential to be a universal treatment for solid tumors, according to researchers at Purdue University.
Dec 10, 2020
0
249
A Purdue University team has developed a novel testing platform to evaluate how breast cancer cells respond to the recurrent stretching that occurs in the lungs during breathing. The technology is designed to better understand ...
Oct 6, 2020
0
27
Many types of human cancers exhibit changes in kinase and phosphatase balances. Drugs that inhibit kinase activity have shown success in the clinic as cancer therapeutics, but the phosphatases still remain a largely underexploited ...
Aug 12, 2020
0
157
About 50% of people who take the drug infliximab for inflammatory bowel diseases, such as Crohn's disease, end up becoming resistant or unresponsive to it.
Aug 4, 2020
0
21
Researchers at Vanderbilt University Medical Center, Purdue University and the University of Wisconsin-Madison have isolated human monoclonal antibodies that potentially can prevent a rare but devastating polio-like illness ...
Jul 3, 2020
0
547
"Mommy brain" is a long-held perception that mothers are more forgetful and less attentive.
Jun 23, 2020
0
62